These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32675844)

  • 1. BAD BUGS, NO DRUGS 2002-2020: PROGRESS, CHALLENGES, AND CALL TO ACTION.
    Boucher HW
    Trans Am Clin Climatol Assoc; 2020; 131():65-71. PubMed ID: 32675844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.
    Spellberg B; Guidos R; Gilbert D; Bradley J; Boucher HW; Scheld WM; Bartlett JG; Edwards J;
    Clin Infect Dis; 2008 Jan; 46(2):155-64. PubMed ID: 18171244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.
    Boucher HW; Talbot GH; Bradley JS; Edwards JE; Gilbert D; Rice LB; Scheld M; Spellberg B; Bartlett J
    Clin Infect Dis; 2009 Jan; 48(1):1-12. PubMed ID: 19035777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.
    Talbot GH; Bradley J; Edwards JE; Gilbert D; Scheld M; Bartlett JG;
    Clin Infect Dis; 2006 Mar; 42(5):657-68. PubMed ID: 16447111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    Kostyanev T; Bonten MJ; O'Brien S; Steel H; Ross S; François B; Tacconelli E; Winterhalter M; Stavenger RA; Karlén A; Harbarth S; Hackett J; Jafri HS; Vuong C; MacGowan A; Witschi A; Angyalosi G; Elborn JS; deWinter R; Goossens H
    J Antimicrob Chemother; 2016 Feb; 71(2):290-5. PubMed ID: 26568581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimicrobial resistance: it is a global crisis, "a slow tsunami"].
    Capozzi C; Maurici M; Panà A
    Ig Sanita Pubbl; 2019; 75(6):429-450. PubMed ID: 32242168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging antibiotic resistance: carbapenemase-producing enterobacteria. Bad new bugs, still no new drugs.
    Spera AM; Esposito S; Pagliano P
    Infez Med; 2019 Dec; 27(4):357-364. PubMed ID: 31846984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go.
    Friedrich AW
    Wien Med Wochenschr; 2019 Feb; 169(Suppl 1):25-30. PubMed ID: 30623278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America.
    Dellinger EP; Gross PA; Barrett TL; Krause PJ; Martone WJ; McGowan JE; Sweet RL; Wenzel RP
    Clin Infect Dis; 1994 Mar; 18(3):422-7. PubMed ID: 8011827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cost of Biological Terrorism.
    Coffey DS
    Oncologist; 1997; 2(6):XI-XII. PubMed ID: 10388077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections.
    Singer AC; Kirchhelle C; Roberts AP
    F1000Res; 2019; 8():238. PubMed ID: 30906539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why Antibiotic Use Data in Animals Needs to Be Collected and How This Can Be Facilitated.
    Pinto Ferreira J
    Front Vet Sci; 2017; 4():213. PubMed ID: 29312963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship.
    Hermsen ED; MacGeorge EL; Andresen ML; Myers LM; Lillis CJ; Rosof BM
    Adv Ther; 2020 Feb; 37(2):918-932. PubMed ID: 31953805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs?
    Rodriguez-Monguio R; Spargo T; Seoane-Vazquez E
    Orphanet J Rare Dis; 2017 Jan; 12(1):1. PubMed ID: 28057032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
    Talbot GH; Jezek A; Murray BE; Jones RN; Ebright RH; Nau GJ; Rodvold KA; Newland JG; Boucher HW;
    Clin Infect Dis; 2019 Jun; 69(1):1-11. PubMed ID: 30715222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications.
    Luepke KH; Suda KJ; Boucher H; Russo RL; Bonney MW; Hunt TD; Mohr JF
    Pharmacotherapy; 2017 Jan; 37(1):71-84. PubMed ID: 27859453
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.